Unlock the Potential of Targeted Cancer Therapies with Our Pyrido[2,3-d]pyrimidin-7(8H)-one Derivative
Discover a critical intermediate for CDK4/6 inhibition, essential for advancing oncology drug development.
Get a Quote & SampleProduct Core Value
![Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]](https://www.nbinno.com/2025/webimg/gemini_6889713a47551_1753837882.png)
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-
This high-purity white powder (≥99%) serves as a vital pharmaceutical intermediate and reference standard. Its molecular structure is instrumental in the synthesis of targeted therapies, particularly in the development of CDK4/6 inhibitors crucial for treating specific types of cancer.
- As a leading supplier of pharmaceutical intermediates, we ensure the highest quality for your research needs.
- Our CAS 571190-30-2 derivative is meticulously manufactured to support your drug development pipelines, especially for CDK4/6 inhibitor research.
- Leverage this compound to advance your understanding of cancer therapy development, utilizing its role in compounds like Palbociclib.
- Benefit from a reliable source for Pyrido[2,3-d]pyrimidin-7(8H)-one derivatives, ensuring consistency in your R&D processes.
Advantages Provided by the Product
Exceptional Purity
Achieve reliable results in your research with our product's guaranteed purity of ≥99%, crucial for accurate pharmaceutical intermediate applications.
Critical for Drug Synthesis
This compound is indispensable for synthesizing advanced pharmaceutical agents, including those targeting cell cycle progression in cancer treatment.
Supports Targeted Therapies
Facilitate the development of next-generation cancer therapies by using a key building block for CDK4/6 inhibitors, enhancing patient outcomes.
Key Applications
Oncology Drug Development
Essential for research and development in targeted cancer therapies, especially those focusing on cell cycle regulation.
Pharmaceutical Intermediates
Serves as a fundamental building block in the complex synthesis pathways of new and existing pharmaceuticals.
Reference Standards
Provides a reliable benchmark for analytical testing and quality control in pharmaceutical manufacturing and research.
CDK Inhibitor Research
Crucial for researchers investigating the mechanisms and applications of CDK4/6 inhibitors like Palbociclib.